In developed countries, the availability of highly active antiretroviral therapy (HAART) has
contributed to a dramatic decrease in mortality and opportunistic infections associated with …

Background: The introduction of highly active antiretroviral therapy (HAART) around 1996
markedly reduced mortality and morbidity from human immunodeficiency virus (HIV) …

A syndrome consisting of metabolic abnormalities (hyperlipidaemia and insulin resistance)
and morphological changes (central fat accumulation and peripheral fat atrophy) has been …

Potent antiretroviral agents markedly suppress HIV and have dramatically improved the
clinical course, prognosis, and survival of HIV-infected patients. Unfortunately, highly active …

HIV-associated lipodystrophy syndrome, also known as fat redistribution syndrome, is an
only recently described disorder consisting of changes in body fat distribution, metabolic …

Since the introduction of HIV-1 protease inhibitors as components of antiretroviral drug
combination regimens, the clinical course of HIV disease and opportunistic infections has …

The HIV associated lipodystrophy syndrome is characterized by fat loss from the periphery,
fat accumulation in the abdominal, dorsocervical regions and breasts, and hyperlipidaemia …

The prognosis of human immunodeficiency virus (HIV)-infected individuals has dramatically
improved worldwide since the introduction of highly antiretroviral therapy. Nevertheless …

A unique and unexpected syndrome consisting of metabolic abnormalities (hyperlipidaemia
and insulin resistance) and body fat redistribution (central adiposity and peripheral fat …

The introduction of highly active antiretroviral therapy (HAART) including nucleoside reverse
transcriptase inhibitors (NRTI) and protease inhibitors (PI) has dramatically improved the …